Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.

Autor: Bottomley A; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Pe M; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Sloan J; 2 Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA., Basch E; 3 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Bonnetain F; 4 Methodology and Quality of Life Unit in Cancer, INSERM U1098, University Hospital of Besançon, Besançon, France., Calvert M; 5 Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Campbell A; 6 Genentech, San Francisco, CA, USA., Cleeland C; 7 Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cocks K; 8 Adelphi Values, Bollington, UK., Collette L; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Dueck AC; 9 Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA., Devlin N; 10 Office of Health Economics, London, UK., Flechtner HH; 11 Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany., Gotay C; 12 School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada., Greimel E; 13 Department of Obstetrics and Gynecology, Medical University Graz, Graz, Austria., Griebsch I; 14 Boehringer Ingelheim, Frankfurt, Germany., Groenvold M; 15 Department of Public Health, University of Copenhagen and Bispebjerg Hospital, Copenhagen, Denmark., Hamel JF; 16 Methodology and Biostatistics Department, University Hospital of Angers UNAM, Angers, France., King M; 17 School of Psychology and Sydney Medical School, University of Sydney, Sydney, NSW, Australia., Kluetz PG; 18 US Food and Drug Administration, Silver Spring, MD, USA., Koller M; 19 Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany., Malone DC; 20 College of Pharmacy, University of Arizona, Tucson, AZ, USA., Martinelli F; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Mitchell SA; 21 Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA., Moinpour CM; 22 Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Musoro JZ; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., O'Connor D; 23 Medicines and Healthcare Products Regulatory Agency, London, UK., Oliver K; 24 International Brain Tumour Alliance, Surrey, UK., Piault-Louis E; 6 Genentech, San Francisco, CA, USA., Piccart M; 25 Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium., Pimentel FL; 26 Blueclinical Phase I, Porto, Portugal.; 27 Centro de Estudos e Investigação em Saúde da Universidade de Coimbra, Coimbra, Portugal., Quinten C; 28 European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden., Reijneveld JC; 29 VU University Medical Center, Department of Neurology & Brain Tumor Center, Amsterdam, The Netherlands., Schürmann C; 30 Institute for Quality and Efficiency in Health Care, Cologne, Germany., Smith AW; 21 Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA., Soltys KM; 31 Health Canada, Ottawa, ON, Canada., Sridhara R; 18 US Food and Drug Administration, Silver Spring, MD, USA., Taphoorn MJB; 32 Leiden University Medical Center/Haaglanden Medical Center, Leiden/The Hague, The Netherlands., Velikova G; 33 Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK., Coens C; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.

Publikováno v: Clinical trials (London, England) [Clin Trials] 2018 Dec; Vol. 15 (6), pp. 624-630. Date of Electronic Publication: 2018 Aug 24.